Metadata
Author: ParaCrawl Corpus
Data
Czech[cs]
Boehringer Ingelheim a Eli Lilly and CompanyV lednu 2011 Boehringer Ingelheim a Eli Lilly and Company oznámily vytvoření aliance v diabetologii, která se zaměřuje na molekuly z několika největších tříd léků na diabetes.
English[en]
About Boehringer Ingelheim and Eli Lilly and Company In January 2011, Boehringer Ingelheim and Eli Lilly and Company entered into an alliance in diabetes that centers on compounds representing several of the largest diabetes treatment classes.